In this episode, Kaitlyn talks with the President and CEO of Neuronetics, Keith Sullivan, about his company’s short-term and long-term goals, the benefits of transcranial magnetic stimulation (TMS) to treat major depressive disorder, how the pandemic has affected mental health, and more.